Home  >  Products  >  ALG10B (asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog B (yeast) ) Blocking Peptide (the middle region of ALG10B)(100ug)
ALG10B (asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog B (yeast) ) Blocking Peptide (the middle region of ALG10B)(100ug)

ALG10B (asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog B (yeast) ) Blocking Peptide (the middle region of ALG10B)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ALG10B Antibody (ARP67353_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP67353
Size: 100ug
Weight: 55kDa
Gene: 144245
Format: Lyophilized powder
Target: ALG10B is a putative alpha-1,2-glucosyltransferase, which adds the third glucose residue to the lipid-linked oligosaccharide precursor for N-linked glycosylation. ALG10B transfers glucose from dolichyl phosphate glucose (Dol-P-Glc) onto the lipid-linked oligosaccharide Glc2Man9GlcNAc(2)-PP-Dol. When coupled to KCNH2 may reduce KCNH2 sensitivity to classic proarrhythmic drug blockade, possibly by mediating glycosylation of KCNH2.
Alternative names: ALG10; KCR1
See Full Product Listings >